Literature DB >> 22011799

Five-year follow-up investigation of bone mineral density by age in premenopausal elite-level long-distance runners.

Karen Hind1, Cathy Zanker, John Truscott.   

Abstract

OBJECTIVE: To evaluate bone mineral density (BMD) by age in premenopausal elite long-distance runners at 2 time points, 5.02 ± 0.5 years apart.
DESIGN: Follow-up study.
SETTING: University Research Institute. PARTICIPANTS: Twenty-three elite-level distance runners (baseline age, 24.9 ± 3.9 years; body mass index, 18.7 ± 1.1; running distance, 89.3 ± 19.4 km/wk) participated in the study. MAIN OUTCOME MEASURES: Dual-energy x-ray absorptiometry (iDXA; GE Healthcare)-derived BMD z-scores for the total body (TB), lumbar spine (LS) (L2-L4), and proximal femur. A z-score of <-1.0 indicated low BMD by age.
RESULTS: Lumbar spine BMD z-scores had increased significantly by follow-up for all runners (baseline, -1.1 ± 0.9; follow-up, -0.7 ± 0.7; P = 0.04) and for formerly amenorrheic runners with restored menstruation (n = 10; baseline, -1.5 ± 0.9; follow-up, -0.9 ± 0.6; P = 0.03). Total body, but not proximal femur z-scores, had also increased (P < 0.05). Improvements in z-scores correlated with an increased body fat (LS: R2 = 0.27; TB: R2 = 0.35; P < 0.01) and menstrual history score (LS: R2 = 0.36; TB: R2 = 0.27; P < 0.05). There were no associations with lean mass or running volume at any skeletal site (P = 0.07-0.89).
CONCLUSIONS: Low BMD by age in highly-trained female runners may be at least partially reversible before the age of 30 years, even when competitive running is continued. This seems to be related to restored menstruation and an increased body fat. Further larger studies are required to clarify our findings.

Entities:  

Mesh:

Year:  2011        PMID: 22011799     DOI: 10.1097/JSM.0b013e3182377257

Source DB:  PubMed          Journal:  Clin J Sport Med        ISSN: 1050-642X            Impact factor:   3.638


  2 in total

1.  Case report: fast reversal of severe osteoporosis after correction of excessive levothyroxine treatment and long-term follow-up.

Authors:  C M Laine; K Landin-Wilhelmsen
Journal:  Osteoporos Int       Date:  2017-03-21       Impact factor: 4.507

Review 2.  Current perspectives on the etiology and manifestation of the "silent" component of the Female Athlete Triad.

Authors:  Rebecca J Mallinson; Mary Jane De Souza
Journal:  Int J Womens Health       Date:  2014-05-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.